» Articles » PMID: 20921021

Germline Mutations in CDH1 Are Infrequent in Women with Early-onset or Familial Lobular Breast Cancers

Abstract

Background: Germline mutations in CDH1 are associated with hereditary diffuse gastric cancer; lobular breast cancer also occurs excessively in families with such condition.

Method: To determine if CDH1 is a susceptibility gene for lobular breast cancer in women without a family history of diffuse gastric cancer, germline DNA was analysed for the presence of CDH1 mutations in 318 women with lobular breast cancer who were diagnosed before the age of 45 years or had a family history of breast cancer and were not known, or known not, to be carriers of germline mutations in BRCA1 or BRCA2. Cases were ascertained through breast cancer registries and high-risk cancer genetic clinics (Breast Cancer Family Registry, the kConFab and a consortium of breast cancer genetics clinics in the United States and Spain). Additionally, Multiplex Ligation-dependent Probe Amplification was performed for 134 cases to detect large deletions.

Results: No truncating mutations and no large deletions were detected. Six non-synonymous variants were found in seven families. Four (4/318 or 1.3%) are considered to be potentially pathogenic through in vitro and in silico analysis.

Conclusion: Potentially pathogenic germline CDH1 mutations in women with early-onset or familial lobular breast cancer are at most infrequent.

Citing Articles

What Is Known about Breast Cancer in Young Women?.

Zhu J, Charkhchi P, Adekunte S, Akbari M Cancers (Basel). 2023; 15(6).

PMID: 36980802 PMC: 10047861. DOI: 10.3390/cancers15061917.


The Identification of Large Rearrangements Involving Intron 2 of the Gene in Negative and Breast Cancer Susceptibility.

Ben Aissa-Haj J, Pinheiro H, Cornelis F, Sebai M, Meseure D, Briaux A Genes (Basel). 2022; 13(12).

PMID: 36553480 PMC: 9778491. DOI: 10.3390/genes13122213.


Frequency of Germline Mutations in Non-Gastric Cancers.

Massari G, Magnoni F, Favia G, Peradze N, Veronesi P, La Vecchia C Cancers (Basel). 2021; 13(10).

PMID: 34066044 PMC: 8151827. DOI: 10.3390/cancers13102321.


Lobular carcinoma in situ: diagnostic criteria and molecular correlates.

Sokolova A, Lakhani S Mod Pathol. 2020; 34(Suppl 1):8-14.

PMID: 33024303 DOI: 10.1038/s41379-020-00689-3.


Frequency and Clinical Characteristics of Unselected Korean Gastric Cancer Patients with a Germline V832M Mutation.

Shin S, Kim Y, Lee J, Lee K J Cancer. 2020; 11(1):208-212.

PMID: 31892987 PMC: 6930413. DOI: 10.7150/jca.36513.


References
1.
Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel M . Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007; 44(11):726-31. PMC: 2752184. DOI: 10.1136/jmg.2007.051268. View

2.
Suriano G, Mulholland D, de Wever O, Ferreira P, Mateus A, Bruyneel E . The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003; 22(36):5716-9. DOI: 10.1038/sj.onc.1206672. View

3.
Keller G, Vogelsang H, Becker I, Plaschke S, Ott K, Suriano G . Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet. 2004; 41(6):e89. PMC: 1735803. DOI: 10.1136/jmg.2003.015594. View

4.
Yabuta T, Shinmura K, Tani M, Yamaguchi S, Yoshimura K, Katai H . E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer. 2002; 101(5):434-41. DOI: 10.1002/ijc.10633. View

5.
Neuhausen S, Ozcelik H, Southey M, John E, Godwin A, Chung W . BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat. 2008; 116(2):379-86. PMC: 2775077. DOI: 10.1007/s10549-008-0153-8. View